Birdwatch Note Rating
2023-03-17 01:50:20 UTC - SOMEWHAT_HELPFUL
Rated by Participant: 3D86537172D85C76B3B195A71F20834FE2ED65900C6B30CB33EB40D015407D2E
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details